The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Nature Cell Biology

• Publication date

  2007-09-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ncb1644PMID 17906618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1

  2007cited by this paper
• Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

  2006cited by this paper
• A heterozygous effect for PINK1 mutations in Parkinson's disease?

  2006cited by this paper
• C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1.

  2006cited by this paper
• PINK1 protein in normal human brain and Parkinson's disease.

  2006cited by this paper
• BIRB796 Inhibits All p38 MAPK Isoforms in Vitro and in Vivo*

  2005cited by this paper
• Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism.

  2005cited by this paper
• Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease.

  2005influential reference
• Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes

  2005cited by this paper
• Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism

  2005cited by this paper
• Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability.

  2005cited by this paper
• Biomedicine. Parkinson's--divergent causes, convergent mechanisms.

  2004cited by this paper
• Regulation of HAX-1 Anti-apoptotic Protein by Omi/HtrA2 Protease during Cell Death*

  2004influential reference
• Homozygous PINK1 C‐terminus mutation causing early‐onset parkinsonism

  2004cited by this paper
• Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.

  2004cited by this paper
• Differentiation-dependent Sensitivity to Apoptogenic Factors in PC12 Cells*

  2004cited by this paper
• Novel PINK1 mutations in early‐onset parkinsonism

  2004cited by this paper
• Neuroprotective Role of the Reaper-Related Serine Protease HtrA2/Omi Revealed by Targeted Deletion in Mice

  2004influential reference
• High content screening applied to large-scale cell biology.

  2004cited by this paper
• Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.

  2004cited by this paper
• Crystal structure of the DegS stress sensor: How a PDZ domain recognizes misfolded protein and activates a protease.

  2004cited by this paper
• Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease.

  2004cited by this paper
• Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1

  2004cited by this paper
• Parkinson's--Divergent Causes, Convergent Mechanisms

  2004cited by this paper
• OMP peptide signals initiate the envelope-stress response by activating DegS protease via relief of inhibition mediated by its PDZ domain.

  2003influential reference
• A stress sensor for the bacterial periplasm.

  2003cited by this paper
• Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis.

  2003influential reference
• MAPKs: new targets for neurodegeneration

  2003cited by this paper
• Binding Specificity and Regulation of the Serine Protease and PDZ Domains of HtrA2/Omi*

  2003influential reference
• Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice

  2003influential reference
• Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs

  2003cited by this paper
• Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi

  2002cited by this paper
• Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.

  2002cited by this paper
• The Serine Protease Omi/HtrA2 Regulates Apoptosis by Binding XIAP through a Reaper-like Motif*

  2002influential reference
• ΔMEKK3:ER* activation induces a p38α/β2-dependent cell cycle arrest at the G2 checkpoint

  2002cited by this paper
• HtrA2 Promotes Cell Death through Its Serine Protease Activity and Its Ability to Antagonize Inhibitor of Apoptosis Proteins*

  2002influential reference
• Identification of Omi/HtrA2 as a Mitochondrial Apoptotic Serine Protease That Disrupts Inhibitor of Apoptosis Protein-Caspase Interaction*

  2002influential reference
• A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death.

  2001influential reference
• Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response.

  2000influential reference
• Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: inhibition by PKB/Akt but not Raf signalling

  2000cited by this paper
• Characterization of a Novel Human Serine Protease That Has Extensive Homology to Bacterial Heat Shock Endoprotease HtrA and Is Regulated by Kidney Ischemia*

  2000cited by this paper
• A temperature-dependent switch from chaperone to protease in a widely conserved heat shock protein.

  1999influential reference
• Mitochondrial reactive oxygen species trigger hypoxia-induced transcription.

  1998cited by this paper
• Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product

  1985cited by this paper

• Targeting PI3K/Akt/mTOR with fisetin mechanistic and therapeutics insights for Parkinson’s disease

  2026cites this paper
• A central role for PINK1 in governing local mitochondrial biogenesis and degradation in neurons

  2026cites this paper
• Phytochemicals and brain health: The effects of curcumin, isoflavonoids, and ouabain.

  2025cites this paper
• Epigenetic Mediating Mechanisms in Parkinson's Disease: The Impact of Educational Attainment on SETD1A Expression

  2025cites this paper
• Parkinson Disease Signaling Pathways, Molecular Mechanisms, and Potential Therapeutic Strategies: A Comprehensive Review

  2025cites this paper
• The mitochondrial intermembrane space – a permanently proteostasis-challenged compartment

  2025influential citation
• Mechanisms Associated with PINK1 Mutations in Parkinson's Disease

  2025cites this paper
• Link between Parkinson’s disease and melanoma: insights into the influence of the PARK gene family

  2025cites this paper
• Post-translational modification and mitochondrial function in Parkinson’s disease

  2024cites this paper
• Structural basis of substrate recognition and allosteric activation of the proapoptotic mitochondrial HtrA2 protease

  2024cites this paper
• Proteases: Role in Various Human Diseases.

  2024cites this paper
• Intron retention as an excellent marker for diagnosing depression and for discovering new potential pathways for drug intervention

  2024cites this paper
• Differential physical interactions of wild-type and S59L mutant CHCHD10 with mitochondrial proteases

  2024cites this paper
• Shared and distinct changes in the molecular cargo of extracellular vesicles in different neurodegenerative diseases

  2024cites this paper
• Unveiling defects of secretion mechanisms in Parkinson’s disease

  2024cites this paper
• Peptide Activator Stabilizes DJ-1 Structure and Enhances Its Activity

  2024cites this paper
• Mitochondria in Health, Disease, and Ageing.

  2023cites this paper
• Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions

  2023cites this paper
• The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?

  2023cites this paper
• Entanglement of MAPK pathways with gene expression and its omnipresence in the etiology for cancer and neurodegenerative disorders.

  2023cites this paper
• GM1 Oligosaccharide Efficacy in Parkinson’s Disease: Protection against MPTP

  2023cites this paper
• Genetic modifiers of synucleinopathies—lessons from experimental models

  2023cites this paper
• Circadian rhythm disruptions associated with opioid use disorder in synaptic proteomes of human dorsolateral prefrontal cortex and nucleus accumbens

  2023cites this paper
• Insights into the Promising Prospect of Pharmacological Approaches Targeting Mitochondrial Dysfunction in Major Human Diseases: At a Glance

  2023cites this paper
• Structural mechanisms of mitochondrial quality control mediated by PINK1 and parkin.

  2023cites this paper
• Insights on the Correlation between Mitochondrial Dysfunction and the Progression of Parkinson's Disease.

  2023cites this paper
• Spoonbill positively regulates JNK signalling mediated apoptosis in Drosophila melanogaster.

  2023cites this paper
• Apoptotic proteins with non-apoptotic activity: expression and function in cancer

  2023cites this paper
• The novel mechanisms of Parkin-dependent mitophagy The novel mechanisms of Parkin-dependent mitophagy SUMMARY IN ESTONIAN DISSERTATIONES NEUROSCIENTIAE UNIVERSITATIS TARTUENSIS

  2022cites this paper
• Structural basis of protein substrate processing by human mitochondrial high-temperature requirement A2 protease

  2022cites this paper
• Oxidative phosphorylation mediated pathogenesis of Parkinson's disease and its implication via Akt signaling.

  2022cites this paper
• Regulation of Neurodegeneration-associated Protein Fragments by the N-degron Pathways

  2022cites this paper
• Mitochondrial-Dependent and Independent Functions of PINK1

  2022cites this paper
• Altered Mitochondrial Protein Homeostasis and Proteinopathies

  2022cites this paper
• Neuron-specific transcriptomic signatures indicate neuroinflammation and altered neuronal activity in ASD temporal cortex

  2022cites this paper
• Deoxyarbutin attenuates severe acute pancreatitis via the HtrA2/PGC-1α pathway

  2022cites this paper
• Targeting Mitochondria as a Therapeutic Approach for Parkinson’s Disease

  2022cites this paper
• Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s Disease

  2022cites this paper
• Dusp26 phosphatase regulates mitochondrial respiration and oxidative stress and protects neuronal cell death

  2022cites this paper
• Genomic, transcriptomic and RNA editing analysis of human MM1 and VV2 sporadic Creutzfeldt-Jakob disease

  2022cites this paper
• Dictyostelium discoideum: A Model System for Neurological Disorders

  2022cites this paper
• Mitochondria in neurodegeneration.

  2022cites this paper
• Pathogenesis of Atrial Fibrillation in Patients with Diabetes Mellitus: Impact on Ablation and Disease Recurrence

  2021cites this paper
• Dissecting the role of interprotomer cooperativity in the activation of oligomeric high-temperature requirement A2 protein

  2021cites this paper
• Neurodegenerative disorders and the current state, pathophysiology and management of Parkinson's disease.

  2021cites this paper
• Importance of Mitochondrial Quality Control in Parkinson’s Disease: The Potential Interplay of Mitochondrial Unfolded Protein Response and Mitophagy

  2021cites this paper
• mRNA microarray profiling identifies a novel circulating HTRA2 for detection of gastric cancer

  2021cites this paper
• Loss of UCHL1 rescues the defects related to Parkinson’s disease by suppressing glycolysis

  2021cites this paper
• PINK1: A Bridge between Mitochondria and Parkinson’s Disease

  2021cites this paper
• Transcription- and phosphorylation-dependent control of a functional interplay between XBP1s and PINK1 governs mitophagy and potentially impacts Parkinson disease pathophysiology

  2021cites this paper
• Loss of GSK-3β mediated phosphorylation in HtrA2 contributes to uncontrolled cell death with Parkinsonian phenotype.

  2021cites this paper
• Understanding the Multiple Role of Mitochondria in Parkinson’s Disease and Related Disorders: Lesson From Genetics and Protein–Interaction Network

  2021cites this paper
• Mitostasis, Calcium and Free Radicals in Health, Aging and Neurodegeneration

  2021cites this paper
• Mitochondrial proteases in human diseases

  2021cites this paper
• The Mitochondrial Kinase PINK1 in Diabetic Kidney Disease

  2021cites this paper
• Copper exposure induces mitochondrial dynamic disorder and oxidative stress via mitochondrial unfolded protein response in pig fundic gland.

  2021cites this paper
• The PINK1-Mediated Crosstalk between Neural Cells and the Underlying Link to Parkinson’s Disease

  2021cites this paper
• Oligomeric assembly regulating mitochondrial HtrA2 function as examined by methyl-TROSY NMR

  2021cites this paper
• Deciphering the dual role and prognostic potential of PINK1 across cancer types

  2020cites this paper
• Kill one or kill the many: interplay between mitophagy and apoptosis

  2020cites this paper
• The multi‐faceted role of mitochondria in the pathology of Parkinson’s disease

  2020cites this paper
• Análisis del efecto neuroprotector de agonistas de receptores nucleares en modelo farmacológico de Parkinson en neuronas dopaminérgicas.

  2020cites this paper
• The mitochondrial network in Parkinson's disease

  2020cites this paper
• Mitophagy regulates integrity of mitochondria at synapses and is critical for synaptic maintenance

  2020cites this paper
• The Mitochondrial Unfolded Protein Response: A Hinge Between Healthy and Pathological Aging

  2020cites this paper
• PINK1: The guard of mitochondria.

  2020cites this paper
• The Endoplasmic Reticulum Stress/Unfolded Protein Response and Their Contributions to Parkinson’s Disease Physiopathology

  2020cites this paper
• Chronic treatment with the complex I inhibitor MPP+ depletes endogenous PTEN-induced kinase 1 (PINK1) via up-regulation of Bcl-2–associated athanogene 6 (BAG6)

  2020cites this paper
• Intramitochondrial proteostasis is directly coupled to α-synuclein and amyloid β1-42 pathologies

  2020cites this paper
• The function of bacterial HtrA is evolutionally conserved in mammalian HtrA2/Omi

  2020cites this paper
• Mechanisms of neurodegeneration in Parkinson's disease: keep neurons in the PINK1.

  2020cites this paper
• Association Between Parkinson’s Disease and Melanoma: Putting the Pieces Together

  2020cites this paper
• N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase

  2020cites this paper
• Mitochondrial E3 Ubiquitin Ligase Parkin: Relationships with Other Causal Proteins in Familial Parkinson’s Disease and Its Substrate-Involved Mouse Experimental Models

  2020cites this paper
• Mitochondria-Associated Proteostasis.

  2020cites this paper
• Mitochondria and Control Defects in a Mouse Model of Gaucher Disease-Links to Parkinson's Disease

  2020cites this paper
• Keeping α-Synuclein at Bay: A More Active Role of Molecular Chaperones in Preventing Mitochondrial Interactions and Transition to Pathological States?

  2020cites this paper
• PINK1/Parkin Mediated Mitophagy, Ca2+ Signalling, and ER–Mitochondria Contacts in Parkinson’s Disease

  2020cites this paper
• Chemical inhibition of FBXO7 reduces inflammation and confers neuroprotection by stabilizing the mitochondrial kinase PINK1.

  2020cites this paper
• Chronic treatment with the complex I inhibitor MPP (cid:2) depletes endogenous PTEN-induced kinase 1 (PINK1) via up-regulation of Bcl-2–associated athanogene 6 (BAG6)

  2020cites this paper
• Dendritic Cells Require PINK1-Mediated Phosphorylation of BCKDE1α to Promote Fatty Acid Oxidation for Immune Function

  2019cites this paper
• Strangers in strange lands: mitochondrial proteins found at extra-mitochondrial locations.

  2019cites this paper
• Neuroprotective effect of anodal transcranial direct current stimulation on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice through modulating mitochondrial dynamics.

  2019cites this paper
• Mitochondrial Proteins in the Development of Parkinson's Disease.

  2019cites this paper
• Characterizing the Function of the N-Terminal Domain of Omi / HtrA 2 2017

  2019cites this paper
• Mitochondrial Dysfunction in Parkinson’s Disease—Cause or Consequence?

  2019cites this paper
• The HSP90 paralog TRAP1 oligomerizes into an OXPHOSregulated protein complex that may be essential for maintaining mitochondrial metabolic homeostasis

  2019influential citation
• Intra-mitochondrial proteostasis is directly coupled to alpha-synuclein and Amyloid β 1-42 pathology

  2019cites this paper
• FBS/BSA media concentration determines CCCP’s ability to depolarize mitochondria and activate PINK1-PRKN mitophagy

  2019cites this paper
• The Neuroprotective Role of the GM1 Oligosaccharide, II3Neu5Ac-Gg4, in Neuroblastoma Cells

  2019cites this paper
• Neuroprotective function of Omi to α-synuclein-induced neurotoxicity.

  2019cites this paper
• The Dictyostelium model for mitochondrial biology and disease.

  2019cites this paper
• Hypoxia regulates the mitochondrial activity of hepatocellular carcinoma cells through HIF/HEY1/PINK1 pathway

  2019cites this paper
• Biomarkers of Parkinson's Disease

  2019cites this paper
• Parkin is a disease modifier in the mutant SOD1 mouse model of ALS

  2018cites this paper
• The circular RNA ACR attenuates myocardial ischemia/reperfusion injury by suppressing autophagy via modulation of the Pink1/ FAM65B pathway

  2018cites this paper
• Current perspective of mitochondrial biology in Parkinson's disease.

  2018cites this paper
• Commentary: Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease

  2018cites this paper
• Oligomeric α-synuclein-specific degradation by HtrA2/Omi to bestow a neuroprotective function

  2018cites this paper
• Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease

  2018cites this paper